New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 4, 2014
06:23 EDTAKRXAkorn guidance 'not a cause for alarm,' says Piper Jaffray
Piper Jaffray believes Akorn's 2014 guidance is "not a cause for alarm" given the depth of the company's pipeline. Piper says Akorn's long-term growth story remains intact and it keeps an Overweight rating on the stock despite lowering its price target for shares to $28 from $29.
News For AKRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 12, 2016
08:46 EDTAKRXAkorn remains a potential takeout target, says RBC Capital
RBC Capital analyst Randall Stanicky says he remains optimistic that Akorn (AKRX) can complete the audit process by May 9 and that the company remains a potential takeout candidate despite one less near-term buyer in Mylan (MYL). Mylan's purchase of Meda puts a potential buyer on the sidelines for now, Stanicky tells investors in a research note. He had viewed Mylan as the most likely suitor followed by Perrigo (PRGO). Applying the price paid for Meda yields a $47 per share buyout price target for Akorn, the analyst notes. He lowered his price target for Akorn shares to $37 from $52 and keeps an Outperform rating on the name.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use